reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

Tevogen Inc.

TVGN · Nasdaq

No reporting failures in the last 12 months

It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.

$64Mpublic float
2025-04-01most recent failure

Score over time

01234202220232024202520262022-07-01 · score 22022-05-17 filed late (10-Q) · accounts not ready2022-04-01 filed late (10-K) · accounts not ready2022-10-01 · score 22022-05-17 filed late (10-Q) · accounts not ready2022-04-01 filed late (10-K) · accounts not ready2023-01-01 · score 22022-05-17 filed late (10-Q) · accounts not ready2022-04-01 filed late (10-K) · accounts not ready2023-04-01 · score 32023-03-31 filed late (10-K) · accounts not ready2022-05-17 filed late (10-Q) · accounts not ready2022-04-01 filed late (10-K) · accounts not ready2023-07-01 · score 22023-05-15 filed late (10-Q) · accounts not ready2023-03-31 filed late (10-K) · accounts not ready2023-10-01 · score 32023-08-15 filed late (10-Q) · acquisition or merger2023-05-15 filed late (10-Q) · accounts not ready2023-03-31 filed late (10-K) · accounts not ready2024-01-01 · score 32023-08-15 filed late (10-Q) · acquisition or merger2023-05-15 filed late (10-Q) · accounts not ready2023-03-31 filed late (10-K) · accounts not ready2024-04-01 · score 22023-08-15 filed late (10-Q) · acquisition or merger2023-05-15 filed late (10-Q) · accounts not ready2024-07-01 · score 42024-05-16 filed late (10-Q) · going concern2024-05-02 auditor change2024-04-02 filed late (10-K) · acquisition or merger2023-08-15 filed late (10-Q) · acquisition or merger2024-10-01 · score 32024-05-16 filed late (10-Q) · going concern2024-05-02 auditor change2024-04-02 filed late (10-K) · acquisition or merger2025-01-01 · score 42024-11-15 filed late (10-Q) · material weakness2024-05-16 filed late (10-Q) · going concern2024-05-02 auditor change2024-04-02 filed late (10-K) · acquisition or merger2025-04-01 · score 42024-11-15 filed late (10-Q) · material weakness2024-05-16 filed late (10-Q) · going concern2024-05-02 auditor change2024-04-02 filed late (10-K) · acquisition or merger2025-07-01 · score 22025-04-01 filed late (10-K) · material weakness2024-11-15 filed late (10-Q) · material weakness2025-10-01 · score 22025-04-01 filed late (10-K) · material weakness2024-11-15 filed late (10-Q) · material weakness2026-01-01 · score 12025-04-01 filed late (10-K) · material weakness2026-04-01 · score 12025-04-01 filed late (10-K) · material weakness

Hover or tap a dot to see the filings behind that score.

Why they said they were late

Tevogen Bio Holdings Inc., a Delaware corporation (the “Company”), was unable to file, without unreasonable effort and expense, its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Form 10-K”), with the Securities and Exchange Commission (the “SEC”) by the prescribed due date, as the Company outsources a portion of its internal accounting and financial reporting function to a third-party and changed service providers in September 2024 and, in connection therewith, requires additional time to finalize its financial statements and accompanying notes to be disclosed in the Form 10-K. The Company will continue to report in its Form 10-K material weaknesses related to its internal controls over financial reporting. The Company expects to file its Form 10-K as soon as practicable and within the extension period of 15 calendar days as provided under Rule 12b-25 under the Securities Exchange Act of 1934, as amended

NT 10-K, filed 2025-04-01 · material weakness

What it filed

2025-04-01filed late (10-K)material weakness SEC →

Tevogen Bio Holdings Inc., a Delaware corporation (the “Company”), was unable to file, without unreasonable effort and expense, its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Form 10-K”), with the Securities and Exchange Commission (the “SEC”) by the prescribed due date, as the Company outsources a portion of its internal accounting and financial reporting function to a third-party and changed service providers in September 2024 and, in connection therewith, requires additional time to finalize its financial statements and accompanying notes to be disclosed in the Form 10-K. The Company will continue to report in its Form 10-K material weaknesses related to its internal controls over financial reporting. The Company expects to file its Form 10-K as soon as practicable and within the extension period of 15 calendar days as provided under Rule 12b-25 under the Securities Exchange Act of 1934, as amended

2024-11-15filed late (10-Q)material weakness SEC →

Tevogen Bio Holdings Inc., a Delaware corporation (the “Company”), was unable to file, without unreasonable effort and expense, its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Q3 Form 10-Q”), with the Securities and Exchange Commission (the “SEC”) within the prescribed time period. The Company outsources a portion of its internal accounting and financial reporting function to a third-party and has recently changed service providers and, in connection therewith, requires additional time to finalize the Company’s financial statements and accompanying notes to be disclosed in the Q3 Form 10-Q. The Company will continue to report in its Q3 Form 10-Q material weaknesses related to its internal controls over financial reporting. The Company plans to file the Q3 Form 10-Q with the SEC as soon as practicable, and no later than the fifth calendar day following the prescribed due date, in accordance with Rule 12b-25

2024-05-16filed late (10-Q)going concern SEC →

Tevogen Bio Holdings Inc., a Delaware corporation (the “Company”) was unable to file, without unreasonable effort and expense, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the “Q1 Form 10-Q”), with the Securities and Exchange Commission (the “SEC”) within the prescribed time period. The Company (formerly known as Semper Paratus Acquisition Corporation) consummated its previously announced business combination (the “Business Combination”) with Tevogen Bio Inc on February 14, 2024. As previously disclosed on Form 12b-25 dated April 2, 2024, due to the timing of the Business Combination, the Company without unreasonable effort or expense, was unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Form 10-K”) within the prescribed time period, and the Company filed the 2023 Form 10-K on April 29, 2024. Due to the additional time needed to complete and file the 2023 Form 10-K, and the substantial amount of resources and procedures and the complexity of accounting associated with the Q1 Form 10-Q, the Company requires additional time to prepare the financial statements and the accompanying notes disclosed in the Q1 Form 10-Q. The Company will continue to report in its Q1 Form 10-Q (i) material weaknesses related to its internal controls over financial reporting and (ii) that substantial doubt exists about its ability to continue as a going concern for one year from the date that the unaudited consolidated financial statements are anticipated to be issued. The Company plans to file the Q1 Form 10-Q with the SEC as soon as practicable, and no later than the fifth calendar day following the prescribed due date, in accordance with Rule 12b-25

2024-05-02auditor changed or resigned SEC →

2024-04-02filed late (10-K)acquisition or merger SEC →

Tevogen Bio Holdings Inc., a Delaware corporation (f/k/a Semper Paratus Acquisition Corporation ) (the “Company”), is unable to file, without unreasonable effort and expense, its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Annual Report”) due to the timing of the Company’s recently consummated business combination with Tevogen Bio Inc, a Delaware corporation, which requires a substantial amount of resources and procedures in connection therewith. As a result, additional time is required to finalize the Company’s financial statements and related disclosures to be filed as part of the 2023 Annual Report. The Company plans to file the 2023 Annual Report with the Securities and Exchange Commission as soon as practicable and within the fifteen calendar day period provided by Rule 12b-25 for delayed filings

2023-08-15filed late (10-Q)acquisition or merger SEC →

Semper Paratus Acquisition Corporation (the “ Company ”) has determined that it is unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023 (the “ Q2 2023 Form 10-Q ”) by the prescribed due date because the Company is in the process of preparing the financial statements for the quarter ended June 30, 2023 and will need additional time to complete such financial statements. The Company anticipates that it will file its Q2 2023 Form 10-Q within the five-day grace period provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended

2023-05-15filed late (10-Q)accounts not ready SEC →

The Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 cannot be filed within the prescribed time period because the Registrant requires additional time to complete its financial statements. The Registrant expects that its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 will be filed on or before the 5th calendar day following the prescribed due date

2023-03-31filed late (10-K)accounts not ready SEC →

The Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022 cannot be filed within the prescribed time period because the Registrant requires additional time to complete its financial statements. The Registrant expects that its Annual Report on Form 10-K for the year ended December 31, 2022 will be filed on or before the 15th calendar day following the prescribed due date

2022-05-17filed late (10-Q)accounts not ready SEC →

The Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 cannot be filed within the prescribed time period because the Registrant requires additional time to complete its financial statements. The Registrant expects that its Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 will be filed on or before the 5th calendar day following the prescribed due date

2022-04-01filed late (10-K)accounts not ready SEC →

The Registrant’s Annual Report on Form 10-K for the year ended December 31, 2021 cannot be filed within the prescribed time period because the Registrant requires additional time to complete its financial statements. The Registrant expects that its Annual Report on Form 10-K for the year ended December 31, 2021 will be filed on or before the 15th calendar day following the prescribed due date

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com